Nearly doubling last year’s Series A, the funding will be used to further development of ultrasound treatment for brain tumors.
Health Care + Med Tech
With two new acquisitions in the animal health space, the Mendota Heights company continues to expand beyond its original focus on dental products.
The positions will be eliminated from the company's Bloomington headquarters as Bright Health retreats from health insurance markets.
Founders are often reticent to talk health insurance, but the consequences of living without it can be dire. What will it take to start the conversation?
Job vacancies in health systems have tripled in one year and, for the first time ever, over half of registered nurses are working part-time, according to a report by the Minnesota Hospital Association.
The medical device giant says it plans to move its patient monitoring and respiratory intervention businesses into a single separate company.
Starting this fall, the Center City-based addiction treatment giant will begin to emphasize a program called Community Reinforcement and Family Training that helps family members build skills that move beyond terms like “enabling” and “tough love.”
The Minneapolis health system and a Boston-based venture capital firm have launched Inbound Health, a new company designed to help other hospitals stand up their own at-home care programs.
Days before the application period opens for 2023 Medicare Advantage plans, the Bloomington-based health insurance startup announced it would cut down its offerings to only Florida and California.
The organization is teaming up with Minnetonka-based Medica to offer a group plan for smaller employers.
The Minneapolis-based comapny says the money will help fund current and future clinical trials.
Headquartered in the D.C. area, carafem joins a slew of other pill-based abortion providers in Minnesota.
The company is developing an artificial artery for bypass surgery.
The partnership is aimed at improving health care outcomes at Walmart clinics by using analytics tools provided by UnitedHealth subsidiary Optum.
The Rochester-based health system has established a program to help found and nurture new companies piloting the latest innovations in gene and cell therapies.
A new agreement with San Diego-based National Resilience Inc. is aimed at making Rochester “a center of excellence for biomanufacturing cell and regenerative technologies.”
A new trial will compare Sonex's device to traditional treatments for carpal tunnel syndrome. CEO Bob Paulson says it may pave the way for wider commercial adoption.
The Minnesota manufacturer is spinning off its multibillion-dollar health care business into a new publicly traded company.